Laurence Duvillard Selected Research

Laurence Duvillard Research Topics

Disease

16	Type 2 Diabetes Mellitus (MODY) 03/2022 - 06/2006
10	Insulin Resistance 11/2014 - 10/2002
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 06/2006
5	Abdominal Obesity 04/2016 - 10/2002
5	Inflammation (Inflammations) 02/2016 - 03/2008
4	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 10/2005
4	Obesity 12/2016 - 06/2006
4	Atherosclerosis 03/2016 - 10/2002
4	Fibrosis (Cirrhosis) 01/2014 - 05/2003
4	Chronic Hepatitis C 12/2007 - 05/2003
3	Hypertriglyceridemia 01/2016 - 10/2002
3	Infections 01/2014 - 05/2003
3	Hyperinsulinism (Hyperinsulinemia) 10/2013 - 07/2011
3	Fatty Liver 04/2012 - 06/2006
2	Hyperaldosteronism (Conn Syndrome) 10/2017 - 11/2016
2	Diabetes Mellitus 01/2017 - 10/2012
2	Splenomegaly 01/2016 - 11/2005
2	Neoplasms (Cancer) 12/2014 - 08/2004
2	Insulinoma 10/2013 - 07/2011
2	Hepatitis C 01/2013 - 05/2003
2	Ischemia 08/2009 - 03/2005
2	Myocardial Infarction 05/2008 - 01/2007
2	Lipodystrophy 03/2006 - 09/2003
1	Shock 10/2019
1	Septic Shock (Toxic Shock Syndrome) 10/2019
1	Thrombosis (Thrombus) 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Non-alcoholic Fatty Liver Disease 02/2017
1	Body Weight (Weight, Body) 02/2017
1	Bacterial Infections (Bacterial Infection) 06/2016
1	Pulmonary Aspergillosis 06/2016
1	Invasive Pulmonary Aspergillosis 06/2016
1	Mycoses (Diseases, Fungus) 06/2016
1	Mucormycosis 06/2016
1	Stroke (Strokes) 04/2016
1	Ischemic Stroke 04/2016
1	Cytopenia 01/2016
1	Sepsis (Septicemia) 01/2016
1	Hyperferritinemia 01/2016

Drug/Important Bio-Agent (IBA)

12	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2002
7	oxidized low density lipoproteinIBA 03/2022 - 10/2002
7	ApolipoproteinsIBA 01/2021 - 05/2003
7	IsotopesIBA 01/2018 - 10/2002
6	HDL CholesterolIBA 01/2022 - 11/2005
5	HDL LipoproteinsIBA 01/2022 - 01/2010
5	Lipoproteins (Lipoprotein)IBA 01/2021 - 10/2002
5	Biological ProductsIBA 10/2017 - 03/2005
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2016 - 06/2006
5	VLDL LipoproteinsIBA 11/2014 - 10/2002
5	Insulin (Novolin)FDA Link 01/2014 - 10/2002
4	Liraglutide FDA Link 03/2022 - 02/2017
4	CholesterolIBA 01/2022 - 08/2009
4	AdipokinesIBA 01/2014 - 04/2005
4	Apolipoproteins B (ApoB)IBA 07/2011 - 10/2002
3	LDL Lipoproteins (beta Lipoproteins)IBA 03/2022 - 10/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 06/2009
3	Biomarkers (Surrogate Marker)IBA 02/2016 - 01/2014
3	ThiazolidinedionesIBA 10/2014 - 04/2005
3	AdiponectinIBA 04/2012 - 04/2005
2	Apolipoprotein C-I (Apolipoprotein C1)IBA 10/2019 - 04/2014
2	ReninIBA 10/2019 - 11/2016
2	ProcalcitoninIBA 06/2016 - 01/2016
2	C-Reactive ProteinIBA 06/2016 - 01/2016
2	Apolipoprotein A-II (Apolipoprotein A2)IBA 04/2016 - 12/2007
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 03/2005
2	LeptinIBA 01/2014 - 12/2007
2	Pharmaceutical PreparationsIBA 01/2013 - 08/2004
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 12/2012 - 04/2012
2	adiponutrinIBA 10/2011 - 12/2010
2	LipidsIBA 01/2010 - 05/2003
2	LDL CholesterolIBA 01/2010 - 06/2009
2	LDL Receptors (LDL Receptor)IBA 08/2009 - 07/2007
2	Rosuvastatin Calcium (Crestor)FDA Link 06/2009 - 03/2008
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 05/2008 - 01/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2008 - 01/2007
1	Proprotein Convertase 9IBA 01/2021
1	SodiumIBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2019
1	BilirubinIBA 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	Apolipoprotein B-48IBA 01/2018
1	Protons (Proton)IBA 02/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2016
1	AldosteroneIBA 11/2016
1	Fibrinogen (Factor I)FDA Link 06/2016
1	hydroxide ionIBA 04/2016
1	25-hydroxyvitamin DIBA 04/2016
1	PlasmalogensIBA 03/2016
1	phosphatidylethanolamineIBA 03/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 03/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2016
1	SphingolipidsIBA 03/2016
1	SphingomyelinsIBA 03/2016
1	SphingosineIBA 03/2016

Therapy/Procedure

8	Therapeutics 02/2017 - 05/2003